Breaking News Instant updates and real-time market news.

RIG

Transocean

$8.54

-0.03 (-0.35%)

, RL

Ralph Lauren

$89.02

0.49 (0.55%)

10:39
08/09/17
08/09
10:39
08/09/17
10:39

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Transocean (RIG) upgraded to Neutral from Sell at Goldman Sachs with analyst Waqar Syed saying Transocean has enhanced the balance sheet over the past several months and now sees leveraged metrics to be relatively better than the peer group in the 2019/2020 time frame. 2. Ralph Lauren (RL) upgraded to Neutral from Underweight at Atlantic Equities. 3. Brink's (BCO) upgraded to Outperform from In-Line at Imperial Capital with analyst Jeff Kessler saying investors have "much to be bullish about" in the second half of 2017 following the company's "strong" first half results and recent acquisitions. 4. Novavax (NVAX) upgraded to Buy from Neutral at Ladenburg with analyst Kevin Degeeter saying he believes the company's NanoFlu could become a "potent vaccine" for prevention of seasonal influenza. 5. Esperion (ESPR) upgraded to Buy from Hold at Jefferies with analyst Michael Yee saying the shares are likely "to keep grinding higher and higher" following the "new de-risking data" for the triple combination. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

RIG

Transocean

$8.54

-0.03 (-0.35%)

RL

Ralph Lauren

$89.02

0.49 (0.55%)

BCO

Brink's

$75.90

-0.65 (-0.85%)

NVAX

Novavax

$0.97

0.0111 (1.16%)

ESPR

Esperion

$52.13

6.96 (15.41%)

  • 10

    Aug

  • 29

    Aug

  • 26

    Sep

  • 10

    Aug

RIG Transocean
$8.54

-0.03 (-0.35%)

07/06/17
BERN
07/06/17
NO CHANGE
BERN
'Global E&P investment to stall in 2018, ' says Bernstein
Bernstein analyst Colin Davies says that global investment in energy exploration and production will slow tremendously next year, falling about 2% globally and rising just 2% in the U.S. He says that E&Ps will have to reduce their rig count next year. In conjunction with the note, the analyst downgraded Noble Corp. (NE) to Underperform from Market Perform, downgraded Transocean (RIG) to Market Perform from Outperform, and downgraded Weatherford (WFT) to Market Perform from Outperform. He upgraded Schlumberger (SLB) to Outperform from Market Perform. Price target on Noble Corp to $2.50 from $7, on Transocean to $9 from $16.50, on Weatherford to $5 from $7, and on Schlumberger to $80 from $94.
07/06/17
BERN
07/06/17
DOWNGRADE
BERN
Market Perform
Transocean downgraded to Market Perform from Outperform at Bernstein
Bernstein analyst Colin Davies downgraded Transocean based on his belief that global investment in energy exploration and production will slow tremendously next year, falling about 2% globally and rising just 2% in the U.S. He says that E&Ps will have to reduce their rig count next year. Target to $9 from $16.50.
08/09/17
08/09/17
UPGRADE

Neutral
Transocean upgraded to Neutral on balance sheet improvements at Goldman Sachs
As previously reported, Goldman upgraded Transocean to Neutral from Sell and lowered its price target to $9.75 from $11.50. Analyst Waqar Syed said Transocean has enhanced the balance sheet over the past several months and now sees leveraged metrics to be relatively better than the peer group in the 2019/2020 timeframe.
08/08/17
GSCO
08/08/17
UPGRADE
GSCO
Neutral
Transocean upgraded to Neutral from Sell at Goldman Sachs
RL Ralph Lauren
$89.02

0.49 (0.55%)

08/09/17
UBSW
08/09/17
NO CHANGE
Target $90
UBSW
Neutral
Ralph Lauren price target raised to $90 from $73 at UBS
UBS analyst Michael Binetti raised his price target on Ralph Lauren following Q2 results but he said he is hesitant to take a more constructive stance on the shares with little visibility to a path back to positive revenue growth. However, he said even with yesterday's stock move, he doesn't think the shares are pricing in a potential for significant earnings upside. Binetti maintained his Neutral rating and raised his price target to $90 from $73 on Ralph Lauren shares.
08/09/17
ATLE
08/09/17
UPGRADE
ATLE
Neutral
Ralph Lauren upgraded to Neutral from Underweight at Atlantic Equities
07/18/17
NEED
07/18/17
INITIATION
NEED
Hold
Ralph Lauren initiated with a Hold at Needham
07/17/17
BUCK
07/17/17
INITIATION
Target $68
BUCK
Neutral
Ralph Lauren assumed with a Neutral at Buckingham
Buckingham analyst Eric Tracy assumed coverage of Ralph Lauren with a Neutral rating and $68 price target.
BCO Brink's
$75.90

-0.65 (-0.85%)

11/28/16
GABE
11/28/16
DOWNGRADE
GABE
Hold
Brink's downgraded to Hold from Buy at Gabelli
08/09/17
IMPC
08/09/17
UPGRADE
Target $86
IMPC
Outperform
Brink's upgraded to Outperform from In-Line at Imperial Capital
Imperial Capital analyst Jeff Kessler upgraded The Brink's Company to Outperform and raised his price target for the shares to $86 from $72. The analyst says investors have "much to be bullish about" in the second half of 2017 following the company's "strong" first half results and recent acquisitions.
12/12/16
MACQ
12/12/16
UPGRADE
MACQ
Outperform
Brink's upgraded to Outperform from Neutral at Macquarie
Macquarie analyst James Clement upgraded Brink's to Outperform and raised its price target to $50 from $38 citing relative valuation and new management's mandate to improve margins. The analyst expects Brink's can increase margins on a consolidated company wide basis by about 100bps annually and market share initiatives that could drive annual revenue growth of 5%.
02/27/17
RHCO
02/27/17
INITIATION
RHCO
Buy
Brink's initiated with a Buy at SunTrust
SunTrust analyst Tobey Sommer initiated Brink's with a Buy rating and a $62 price target, citing margin growth.
NVAX Novavax
$0.97

0.0111 (1.16%)

12/16/16
CANT
12/16/16
INITIATION
Target $2
CANT
Neutral
Novavax initiated with a Neutral at Cantor
Cantor Fitzgerald analyst William Tanner started Novavax with a Neutral rating and $2 price target.
08/09/17
LTCO
08/09/17
UPGRADE
Target $1.6
LTCO
Buy
Novavax upgraded to Buy from Neutral at Ladenburg
Ladenburg Thalmann analyst Kevin Degeeter upgraded Novavax to Buy with a $1.60 price target. The analyst believes the company's NanoFlu could become a "potent vaccine" for prevention of seasonal influenza.
09/16/16
09/16/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. 21st Century Fox (FOX, FOXA) downgraded to Market Perform from Outperform at Bernstein with analyst Jason Park citing a reduction in his estimates for the company's Star India business. 2. Wells Fargo (WFC) downgraded to Underweight from Neutral at Atlantic Equities. 3. Citi (C) downgraded to Neutral from Buy at Goldman with analyst Richard Ramsden saying Citi's expected earnings inflection has failed to materialize and ROEs are at 7.7%, well below management's 10% target. 4. McCormick (MKC) downgraded to Market Perform from Outperform at Bernstein with analyst Alexia Howard citing valuation. 5. Novavax (NVAX) downgraded to Neutral from Overweight at Piper Jaffray, to Neutral from Overweight at JPMorgan, to Neutral from Buy at Ladenburg, to Neutral from Outperform at Wedbush, and to Neutral from Buy at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/16/16
SBSH
09/16/16
DOWNGRADE
Target $1.5
SBSH
Neutral
Novavax downgraded to Neutral from Buy at Citi
Citi analyst Joel Beatty downgraded Novavax to Neutral after the company's RSV vaccine for older adults failed in Phase 3. The analyst does not expect results from the one remaining clinical trial until 2019. He cut his price target for the shares to $1.50 from $12. Four other firms downgraded Novavax this morning.
ESPR Esperion
$52.13

6.96 (15.41%)

08/08/17
NEED
08/08/17
NO CHANGE
Target $72
NEED
Buy
Esperion price target raised to $72 from $58 at Needham
Needham analyst Chad Messer raised Esperion's price target to $72 from $58 following positive triple combination data for bempedoic acid and improved regulatory timelines for filings. The analyst has a Buy rating on Esperion shares.
07/10/17
JEFF
07/10/17
INITIATION
Target $55
JEFF
Hold
Esperion initiated with a Hold at Jefferies
Jefferies initiated Esperion with a Hold and a $55 price target.
08/09/17
JEFF
08/09/17
UPGRADE
Target $85
JEFF
Buy
Esperion upgraded to Buy with $85 price target at Jefferies
Jefferies analyst Michael Yee last night upgraded Esperion Therapeutics to Buy from Hold and raised his price target for the shares to $85 from $55. The shares are likely "to keep grinding higher and higher" following the "new de-risking data" for the triple combination, Yee tells investors in a research note. The analyst sees potential partnership opportunities as a "big catalyst."
08/08/17
JEFF
08/08/17
UPGRADE
JEFF
Buy
Esperion upgraded to Buy from Hold at Jefferies

TODAY'S FREE FLY STORIES

10:30
11/23/17
11/23
10:30
11/23/17
10:30
General news
FX Action: EUR-USD, USD-JPY and other major pairings are in sideways mode »

FX Action: EUR-USD,…

DE

Deere

$145.25

6.02 (4.32%)

09:53
11/23/17
11/23
09:53
11/23/17
09:53
Upgrade
Deutsche Bank gets off sidelines, upgrades Deere shares to Buy »

Deutsche Bank analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

08:55
11/23/17
11/23
08:55
11/23/17
08:55
General news
FX Update: USD-CAD vaulted upwards on weak Canadian data »

FX Update: USD-CAD…

08:30
11/23/17
11/23
08:30
11/23/17
08:30
General news
FX Action: The USD index (DXY) logged a one-month low »

FX Action: The USD index…

TSLA

Tesla

$312.60

-5.21 (-1.64%)

08:08
11/23/17
11/23
08:08
11/23/17
08:08
Hot Stocks
Tesla CEO highlights 'record time' on Australian ion battery »

Tesla CEO Elon Musk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

TSLA

Tesla

$312.60

-5.21 (-1.64%)

08:07
11/23/17
11/23
08:07
11/23/17
08:07
Hot Stocks
Tesla completes construction on largest lithium ion battery in Australia »

The South Australian…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

GSK

GlaxoSmithKline

$35.06

0.25 (0.72%)

, INVA

Innoviva

$13.42

0.01 (0.07%)

07:56
11/23/17
11/23
07:56
11/23/17
07:56
Hot Stocks
GSK, Innoviva submit data to FDA for expanded Trelegy Ellipta label »

GlaxoSmithKline (GSK) and…

GSK

GlaxoSmithKline

$35.06

0.25 (0.72%)

INVA

Innoviva

$13.42

0.01 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVM

Silvercorp Metals

$2.51

-0.07 (-2.71%)

07:52
11/23/17
11/23
07:52
11/23/17
07:52
Hot Stocks
Silvercorp Metals to buy back up to 5% of shares »

Silvercorp Metals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEL

Cellcom Israel

$10.00

-0.1 (-0.99%)

07:49
11/23/17
11/23
07:49
11/23/17
07:49
Hot Stocks
Cellcom Israel now second layer company according to Concentration Law »

Cellcom Israel announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GASS

StealthGas

$4.07

0.36 (9.70%)

07:06
11/23/17
11/23
07:06
11/23/17
07:06
Recommendations
StealthGas analyst commentary at Jefferies »

StealthGas trades at only…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRT

Copart

$41.01

4.31 (11.74%)

07:02
11/23/17
11/23
07:02
11/23/17
07:02
Recommendations
Copart analyst commentary at Jefferies »

Copart price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

DE

Deere

$145.25

6.02 (4.32%)

06:56
11/23/17
11/23
06:56
11/23/17
06:56
Upgrade
Deere rating change at Deutsche Bank »

Deere upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

DE

Deere

$145.25

6.02 (4.32%)

06:55
11/23/17
11/23
06:55
11/23/17
06:55
Recommendations
Deere analyst commentary at Wells Fargo »

Deere price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

06:40
11/23/17
11/23
06:40
11/23/17
06:40
General news
FX Update: The dollar has remained on a weakening track »

FX Update: The dollar has…

SECO

Seeco Holding

$8.34

0.14 (1.71%)

04:55
11/23/17
11/23
04:55
11/23/17
04:55
Conference/Events
Seeco Holding management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Nov

04:55
11/23/17
11/23
04:55
11/23/17
04:55
Conference/Events
Deutsche Bank to hold a conference »

Thailand SET Corporate…

04:55
11/23/17
11/23
04:55
11/23/17
04:55
Conference/Events
RBC Capital to hold field trip »

European Utilities Field…

BASFY

BASF

$27.39

-0.13 (-0.47%)

04:55
11/23/17
11/23
04:55
11/23/17
04:55
Conference/Events
BASF management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Nov

  • 24

    Nov

RBS

RBS

$7.30

-0.04 (-0.54%)

04:55
11/23/17
11/23
04:55
11/23/17
04:55
Conference/Events
RBS management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Nov

  • 24

    Nov

04:25
11/23/17
11/23
04:25
11/23/17
04:25
General news
FX Action: USD-CAD punched out a 10-day low »

FX Action: USD-CAD…

02:35
11/23/17
11/23
02:35
11/23/17
02:35
General news
FX Update: The dollar has remained on a downward path »

FX Update: The dollar…

L

Loews

$49.36

-0.02 (-0.04%)

, GE

General Electric

$18.15

0.32 (1.79%)

18:41
11/22/17
11/22
18:41
11/22/17
18:41
Hot Stocks
Loews CEO James Tisch buys 3M shares of General Electric »

In a regulatory filing,…

L

Loews

$49.36

-0.02 (-0.04%)

GE

General Electric

$18.15

0.32 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRFS

BRF S.A.

$12.77

-0.16 (-1.24%)

18:06
11/22/17
11/22
18:06
11/22/17
18:06
Hot Stocks
BRF S.A. names Jose Aurelio Drummond Jr. as CEO »

BRF S.A. hereby informs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SU

Suncor

$35.42

0.2 (0.57%)

18:02
11/22/17
11/22
18:02
11/22/17
18:02
Hot Stocks
Suncor closes sale of equity interest in East Tan Farm, redeems $750M in debt »

Suncor successfully…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SAP

SAP

$113.85

-1.44 (-1.25%)

17:53
11/22/17
11/22
17:53
11/22/17
17:53
Periodicals
SAP launches investigation of sales practices in Gulf region, Reuters reports »

SAP has launched a formal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.